Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Bladder cancer; Breast cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Renal cancer; Sarcoma; Thyroid cancer
- Focus Adverse reactions
- Acronyms VOTRAGE
- 29 May 2015 According to an abstract presented at 51st Annual Meeting of the American Society of Clinical Oncology11 patients have been recruited till date.
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 05 Sep 2014 Planned End Date changed from 1 Feb 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.